MAGICL hs-cTnl (CLlA) is intended for the in vitro quantitative determination of high-sensitivity cardiac troponin l (hs-cTnl) in human serum, plasma and whole blood samples.
MAGICL hs-cTnT (CLlA) is intended for the in vitro quantitative determination of highly-sensitive cardiac troponin T (hs-cTnT) in human serum, plasma or whole blood.
MAGICL NT-proBNP (CLlA) is intended for the in vitro quantitative determination of N-terminal pro B-type natriuretic peptide (NT-proBNP) in human serum, plasma and whole blood.
MAGICL BNP (CLIA) is intended for the in vitro quantitative determination of human B-type natriuretic peptide (BNP) in human plasma and whole blood samples.
MAGICL CK-MB (CLIA) is intended for the in vitro quantitative determination of Creatine Kinase-MB (CK-MB) in human serum, plasma or whole blood samples.
MAGICL H-FABP (CLIA) is intended for the in vitro quantitative determination of heart type-fatty acid binding protein (H-FABP) in human serum, plasma or whole blood.
MAGICL PCT (CLIA) is intended for the in vitro quantitative determination of procalcitonin (PCT) in human serum, plasma, whole blood or peripheral blood.
MAGICL hs-cTnl (CLlA) is intended for the in vitro quantitative determination of high-sensitivity cardiac troponin l (hs-cTnl) in human serum, plasma and whole blood samples.
MAGICL hs-cTnT (CLlA) is intended for the in vitro quantitative determination of highly-sensitive cardiac troponin T (hs-cTnT) in human serum, plasma or whole blood.
MAGICL NT-proBNP (CLlA) is intended for the in vitro quantitative determination of N-terminal pro B-type natriuretic peptide (NT-proBNP) in human serum, plasma and whole blood.
MAGICL BNP (CLIA) is intended for the in vitro quantitative determination of human B-type natriuretic peptide (BNP) in human plasma and whole blood samples.
MAGICL CK-MB (CLIA) is intended for the in vitro quantitative determination of Creatine Kinase-MB (CK-MB) in human serum, plasma or whole blood samples.
MAGICL H-FABP (CLIA) is intended for the in vitro quantitative determination of heart type-fatty acid binding protein (H-FABP) in human serum, plasma or whole blood.
MAGICL PCT (CLIA) is intended for the in vitro quantitative determination of procalcitonin (PCT) in human serum, plasma, whole blood or peripheral blood.